| scholarly article | Q13442814 |
| P2093 | author name string | G T Macfarlane | |
| J H Cummings | |||
| S Macfarlane | |||
| E Furrie | |||
| P2860 | cites work | Protein degradation by human intestinal bacteria | Q68929525 |
| The association of autoimmune disorders with inflammatory bowel disease | Q69433210 | ||
| Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis | Q69452848 | ||
| Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) | Q70823350 | ||
| Experimental models of inflammatory bowel disease | Q71737271 | ||
| Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCR alpha mutant mice with inflammatory bowel disease | Q71784308 | ||
| Induction and prevention of colonic inflammation in IL-2-deficient mice | Q71968278 | ||
| Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice | Q72233696 | ||
| Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases | Q72271487 | ||
| Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis | Q72688420 | ||
| Mucosa-associated bacterial flora of the human colon | Q72998553 | ||
| The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls | Q73118358 | ||
| Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells | Q73882494 | ||
| pANCA represents a cross-reactivity to enteric bacterial antigens | Q74419136 | ||
| Divergent roles for Fc receptors and complement in vivo | Q74578137 | ||
| Differential lamina propria cell migration via basement membrane pores of inflammatory bowel disease mucosa | Q77349954 | ||
| Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study | Q77494204 | ||
| Ciprofloxacin as a treatment for ulcerative colitis—not yet | Q77494310 | ||
| Ulcerative colitis | Q77601258 | ||
| Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis | Q78766823 | ||
| Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice | Q24523182 | ||
| Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene | Q28593669 | ||
| Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide | Q29547245 | ||
| Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity | Q29617967 | ||
| Colonic bacteria express an ulcerative colitis pANCA-related protein epitope | Q31518042 | ||
| Colitis in transgenic and knockout animals as models of human inflammatory bowel disease | Q33713331 | ||
| Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. | Q33770100 | ||
| Recent developments in the immunology of inflammatory bowel disease | Q33815932 | ||
| Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line | Q33858496 | ||
| Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice | Q34006798 | ||
| Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody | Q34009198 | ||
| Bacteria as the cause of ulcerative colitis | Q34104389 | ||
| Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis | Q34408590 | ||
| Immune-complex mediated colitis in rabbits. An experimental model | Q34474099 | ||
| Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro | Q34522706 | ||
| Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis | Q34528243 | ||
| Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role | Q35351273 | ||
| Biased JH usage in plasma cell immunoglobulin gene sequences from colonic mucosa in ulcerative colitis but not in Crohn's disease | Q35354348 | ||
| Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis | Q35594741 | ||
| In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis | Q35594777 | ||
| The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats | Q36364133 | ||
| Inflammatory bowel disease (1) | Q37278321 | ||
| Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease | Q37357109 | ||
| Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats | Q39769547 | ||
| Oxidants and free radicals in inflammatory bowel disease | Q40625906 | ||
| Distribution of IgA 1 and IgA 2 plasma cells in various normal human tissues and in the jejunum of plasma IgA-deficient patients | Q40965087 | ||
| Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease | Q41084555 | ||
| Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis | Q41157368 | ||
| Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease. | Q41682901 | ||
| Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis | Q41725173 | ||
| Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease | Q41746265 | ||
| Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria | Q42021859 | ||
| Induction and function of vascular adhesion protein-1 at sites of inflammation | Q42942033 | ||
| Mucosal flora in inflammatory bowel disease | Q43503928 | ||
| A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease | Q46520994 | ||
| The rectal mucosa-associated microflora in patients with ulcerative colitis | Q49169267 | ||
| Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon | Q68188688 | ||
| Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture | Q68739212 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| ulcerative colitis | Q1477 | ||
| P304 | page(s) | 91-98 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response | |
| P478 | volume | 53 |
| Q48189523 | A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis |
| Q34975747 | Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs |
| Q33787065 | Association of levels of antibodies from patients with inflammatory bowel disease with extracellular proteins of food and probiotic bacteria. |
| Q36809889 | Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation |
| Q47721394 | Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer |
| Q43945848 | Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis |
| Q91688055 | Complex Bacterial Consortia Reprogram the Colitogenic Activity of Enterococcus faecalis in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated Colitis |
| Q24685931 | Dysbiosis in inflammatory bowel disease |
| Q36261533 | Dysregulation of Systemic and Mucosal Humoral Responses to Microbial and Food Antigens as a Factor Contributing to Microbial Translocation and Chronic Inflammation in HIV-1 Infection. |
| Q36065887 | Effect of traditional Chinese medicinal enemas on ulcerative colitis of rats |
| Q42204935 | Effects of Changtai granules, a traditional compound Chinese medicine, on chronic trinitrobenzene sulfonic acid-induced colitis in rats |
| Q98210300 | Effects of herb-partitioned moxibustion for ulcerative colitis: A protocol for systematic review and meta-analysis |
| Q34139719 | Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa–bacteria interactions |
| Q44080427 | Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. |
| Q39980223 | Genetic polymorphisms of CYP2D6 oxidation in patients with inflammatory bowel disease |
| Q42151699 | Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. |
| Q28732754 | Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota |
| Q92340472 | Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease |
| Q35596449 | Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction |
| Q37502056 | Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. |
| Q50045140 | Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines |
| Q53241323 | Inflammatory Bowel Disease |
| Q37529381 | Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy |
| Q34523427 | Longitudinal Analyses of Gut Mucosal Microbiotas in Ulcerative Colitis in Relation to Patient Age and Disease Severity and Duration |
| Q37123770 | Microbial host interactions in IBD: implications for pathogenesis and therapy |
| Q54425959 | Microflora in Crohn's disease: the emergence of adherent and invasive Escherichia coli |
| Q42793741 | Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells |
| Q41830808 | NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkappa-B and iNOS. |
| Q91820039 | Pathogenicity of Enterococci |
| Q27693862 | Pulmonary-intestinal cross-talk in mucosal inflammatory disease |
| Q38702350 | Rationale for Using of Bifidobacterium Probiotic Strains-Fermented Milk Against Colitis Based on Animal Experiments and Clinical Trials |
| Q38177271 | Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design. |
| Q35661462 | Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels |
| Q37987289 | Systemic antibody responses to gut microbes in health and disease |
| Q54482520 | Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria |
| Q36636016 | What is the origin of ulcerative colitis? Still more questions than answers |
Search more.